全文获取类型
收费全文 | 36798篇 |
免费 | 3573篇 |
国内免费 | 860篇 |
专业分类
耳鼻咽喉 | 273篇 |
儿科学 | 846篇 |
妇产科学 | 445篇 |
基础医学 | 1739篇 |
口腔科学 | 865篇 |
临床医学 | 6808篇 |
内科学 | 4201篇 |
皮肤病学 | 350篇 |
神经病学 | 2577篇 |
特种医学 | 1238篇 |
外国民族医学 | 3篇 |
外科学 | 3454篇 |
综合类 | 4416篇 |
现状与发展 | 1篇 |
一般理论 | 9篇 |
预防医学 | 5774篇 |
眼科学 | 518篇 |
药学 | 4436篇 |
98篇 | |
中国医学 | 1280篇 |
肿瘤学 | 1900篇 |
出版年
2024年 | 101篇 |
2023年 | 834篇 |
2022年 | 1236篇 |
2021年 | 1766篇 |
2020年 | 1818篇 |
2019年 | 1749篇 |
2018年 | 1682篇 |
2017年 | 1623篇 |
2016年 | 1636篇 |
2015年 | 1493篇 |
2014年 | 2509篇 |
2013年 | 3538篇 |
2012年 | 1948篇 |
2011年 | 2155篇 |
2010年 | 1751篇 |
2009年 | 1569篇 |
2008年 | 1578篇 |
2007年 | 1679篇 |
2006年 | 1420篇 |
2005年 | 1335篇 |
2004年 | 1109篇 |
2003年 | 926篇 |
2002年 | 793篇 |
2001年 | 810篇 |
2000年 | 658篇 |
1999年 | 520篇 |
1998年 | 459篇 |
1997年 | 356篇 |
1996年 | 310篇 |
1995年 | 249篇 |
1994年 | 253篇 |
1993年 | 211篇 |
1992年 | 196篇 |
1991年 | 209篇 |
1990年 | 134篇 |
1989年 | 98篇 |
1988年 | 76篇 |
1987年 | 61篇 |
1986年 | 66篇 |
1985年 | 63篇 |
1984年 | 64篇 |
1983年 | 32篇 |
1982年 | 32篇 |
1981年 | 30篇 |
1980年 | 29篇 |
1979年 | 24篇 |
1978年 | 11篇 |
1976年 | 6篇 |
1975年 | 8篇 |
1974年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
智力残疾的适应性行为评估 总被引:1,自引:1,他引:0
适应性行为评估是智力残疾诊断与干预的必要依据。适应性行为的概念至今仍未有统一的观点,AAMR(2002)认为,适应性行为指的是概念、社会和应用3方面的技能,它的限制会影响个体的日常生活运作,进而影响其生活适应。对适应性行为进行评估的方法主要有测验法、行为观察法、功能性评估、生活质量评估和社会技能测量。无论使用什么方法进行评估,都应当以改善智力残疾个体现有状况为目的,考虑到各种评估方法的局限性,对智力残疾个体宜进行全面评估。 相似文献
102.
特异性荧光偏振免疫法监测521例肾移植后环孢素A全血浓度3275次 总被引:2,自引:0,他引:2
目的通过监测肾移植后病人环孢素A(CsA)全血浓度 ,提出CsA在三联免疫抑制用药方案中的理想治疗窗。方法用特异性荧光偏振免疫法测定CsA全血浓度 ,对521例病人监测3275次 ,按术后时间及临床表现分组比较。结果肾移植后<1 ,、1~3、3~6、6~12个月、1~2和>2年的CsA全血谷浓度的理想治疗窗应分别为250~450、200~400、150~300、100~250、100~200和100~180μg/L。结论CsA全血浓度在上述范围内 ,中毒反应和排异反应明显减少 相似文献
103.
S. Moss H. Prosser B. Ibbotson D. Goldberg 《Journal of intellectual disability research : JIDR》1996,40(5):457-465
This paper investigates differences in the nature and frequency of psychiatric symptoms reported by patients with learning disability and by key informants. The study involved psychiatric assessment of 100 patients with learning disabilities and key informants using the Psychiatric Assessment Schedule for Adults with a Developmental Disability (PAS-ADD), a semi-structured psychiatric interview developed specifically for people who have a learning disability. There was considerable disagreement between respondent and informant interviews; only 40.7% of cases were detected by both interviews. Respondents were more likely to report on autonomic symptoms and certain psychotic phenomena. Other anxiety and depression symptoms were more frequently reported by infcrnnants. The results indicate that it is crucial for sensitive case detection to complete both interviews where possible. If the respondent cannot be interviewed, panic disorder or phobias may be particularly difficult to detect. 相似文献
104.
105.
米非司酮配伍卡前列甲酯89例与米非司酮配伍米索前列醇110例终止早期妊娠的比较 总被引:4,自引:0,他引:4
目的:比较米非司酮配伍卡前列甲酯与米非司酮配伍米索前列醇终止早期妊娠的疗效。方法:妊娠≤49d孕妇199例,年龄26±5a,随机分A组89例,B组110例。2组均用米非司酮25mg,bid,3d,于d4,A组阴道后穹窿置卡前列甲酯栓1mg。B组米索前列醇po,600μg。结果:A和B组完全流产率各为83%和93.6%,经X2检验,P<0.05;胎囊排出时间,A组4±5h,B组3±6h,2组无显著差异。结论:米非司酮配伍米索前列醇的抗早孕效果优于配伍卡前列甲酯。 相似文献
106.
107.
Flemming M. Nilsson Birgitte L. Hansen Christian Büchel Wagner F. Gattaz Jes Gerlach 《European archives of psychiatry and clinical neuroscience》1996,246(2):71-77
Digital movment analysis (DMA) is a new instrumental approach to assessing oral tardive dyskinesia (TD) by means of digital image processing of a video signal, tracking five paper dots placed around the patient's mouth. A total of 40 schizophrenic patients, 30 with and 10 without TD, were examined twice (with a 3-month interval) with this new device. The patients were further examined with two TD rating scales: the St. Hans Rating Scale for extrapyramidal syndromes (SHRS) and the Abnormal Involuntary Movement Scale (AIMS).The schizophrenic patients accepted the instrumental assessment without any anxiety or resistance. The internal relibility of the apparatus was high, with correlation coefficients of 0.80–0.99. The DMA TD values correlated with the SHRS and AIMS scores with correlation coefficients of 0.48–0.73 indicating an acceptable, although not strong, concurrent validity. Fluctuations occurred from the first to the second examination independent of medication. For these fluctuations no correlation was found between DMA values and rating scores. Finally, the DMA device was able to detect perioral tremor as a sign of parkinsonism.It has been concluded that DMA is a useful supplement to classical TD rating, although further validity evaluation is warranted. 相似文献
108.
L. Niskanen H. Enlund V. Jormanainen A. Nissinen M. Uusitupa 《European journal of clinical pharmacology》1994,46(2):101-105
The utilisation of antidiabetic drugs reflects both the prevalence of diabetes and the different therapeutic traditions of physicians. A questionnaire survey to study attitudes to the use of oral antidiabetic drugs amongst physicians and possible changes in treatment habits was carried out in a representative sample of Finnish physicians (n=454) in 1992 and the results were compared with those of a similar survey carried out in 1985, and with drug utilisation statistics.The mean fasting blood glucose level at which a physician would start pharmacological treatment was 8.7 mmol·l–1, which was significantly lower than in the 1985 survey. The responses to various case histories suggested a more active approach to pharmacological treatment compared to the 1985 survey. Insulin treatment especially seems to have gained in popularity. This change in attitude was paralled by an increase in the consumption of antidiabetic drugs in Finland during the observation period. The increase in use of oral drugs was steeper in Finland than in Norway and Sweden.Whether this active approach will improve the metabolic control and prognosis of patients with Type 2 diabetes, remains to be demonstrated. 相似文献
109.
G. Miremont F. Haramburu B. Bégaud J. C. Péré J. Dangoumau 《European journal of clinical pharmacology》1994,46(4):285-289
Since spontaneous reporting of adverse drug reactions depends on the physician's opinion of the relationship between the drug and the adverse event, we compared physicians' opinions with the scores obtained by the causality assessment method used in France. During a 2 month period, all physicians who reported adverse drug reactions (ADRs) to our pharmacovigilance centre expressed their opinions on the causal link by means of visual analogue scales. ADR reports were then assessed with the French causality assessment method by a clinical pharmacologist who was blind to physicians' opinions.The assessment by both physicians and the standardized method was performed for 75 ADR cases involving 120 drugs. Physicians used a wide range of assessments, with a preponderance of extreme scores, resulting in a U-shaped distribution, while the standardized method gave generally low scores. Scores given by physicians were very high (causality considered very likely or likely) in 60% of cases and very low (causality considered unlikely or dubious/possible) in 32% of cases. Scores obtained using the causality assessment method were low (causality dubious/possible) in 89% of cases and causality considered likely in only 11 cases, essentially in cases with positive rechallenge. Complete agreement occurred in only 6% of cases. Adding complete agreement and minor discrepancies raised the percentage to 49%. 相似文献
110.
R. Schall F. O. Müller H. K. L. Hundt L. Duursema G. Groenewoud M. Van Dyk A. M. C. Van Schalkwyk 《Biopharmaceutics & drug disposition》1994,15(6):493-503
Four controlled-release nifedipine products were investigated in two clinical studies. In study 1, 22 healthy male volunteers took part in an open, multiple-dose, randomized, crossover study to determine the relative bioavailablity of two 10 mg controlled-release nifedipine tablet (Adalat® Retard, Bayer), administered 12 hourly, and one 20 mg controlled-release nifedipine tablet (Adalat® Retard, Bayer) administered 12 hourly. In study 2, 24 healthy male volunteers took part in an open, multiple-dose, randomized, three-period, crossover study to determine the relative bioavailability of (i) two 30 mg nifedipine gastro-intestinal therapeutic system (GITS) tablets (Adalat® XL, Bayer) administered once daily; (ii) one 60 mg nifedipine GITS tablet (Adalat® XL, Bayer) administered once daily; and (iii) one 20 mg plus one 10 mg nifedipine controlled-release tablet (Adalat® Retard, Bayer), administered 12 hourly. In both studies detailed pharmacokinetic data, in particular with respect to the controlled-release characteristics of the different formulations, were collected. Results of both studies indicate that all nifedipine products investigated are bioequivalent with respect to the extent of absorption of nifedipine. The nifedipine GITS products (Adalat® XL) have better controlled-release properties than the Adalat® Retard product, and are suitable for once-a-day administration. 相似文献